{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["44(10)"],"submitter":["Chen SY"],"pubmed_abstract":["Activation of NLR family pyrin domain-containing 3 (NLRP3) inflammasome plays important role in defending against infections, but its aberrant activation is causally linked to many inflammatory diseases, thus being a therapeutic target for these diseases. Theaflavin, one major ingredient of black tea, exhibits potent anti-inflammatory and anti-oxidative activities. In this study, we investigated the therapeutic effects of theaflavin against NLRP3 inflammasome activation in macrophages in vitro and in animal models of related diseases. We showed that theaflavin (50, 100, 200 μM) dose-dependently inhibited NLRP3 inflammasome activation in LPS-primed macrophages stimulated with ATP, nigericin or monosodium urate crystals (MSU), evidenced by reduced release of caspase-1p10 and mature interleuk"],"journal":["Acta pharmacologica Sinica"],"pagination":["2019-2036"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10545837"],"repository":["biostudies-literature"],"pubmed_title":["Theaflavin mitigates acute gouty peritonitis and septic organ injury in mice by suppressing NLRP3 inflammasome assembly."],"pmcid":["PMC10545837"],"pubmed_authors":["Shi ZJ","Yuan T","Xu LH","Chen SY","Zha QB","Li YP","Xu R","He XH","Liang QQ","You YP","Zhang HR","Ou-Yang DY"],"additional_accession":[]},"is_claimable":false,"name":"Theaflavin mitigates acute gouty peritonitis and septic organ injury in mice by suppressing NLRP3 inflammasome assembly.","description":"Activation of NLR family pyrin domain-containing 3 (NLRP3) inflammasome plays important role in defending against infections, but its aberrant activation is causally linked to many inflammatory diseases, thus being a therapeutic target for these diseases. Theaflavin, one major ingredient of black tea, exhibits potent anti-inflammatory and anti-oxidative activities. In this study, we investigated the therapeutic effects of theaflavin against NLRP3 inflammasome activation in macrophages in vitro and in animal models of related diseases. We showed that theaflavin (50, 100, 200 μM) dose-dependently inhibited NLRP3 inflammasome activation in LPS-primed macrophages stimulated with ATP, nigericin or monosodium urate crystals (MSU), evidenced by reduced release of caspase-1p10 and mature interleuk","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Oct","modification":"2025-04-21T14:53:25.294Z","creation":"2025-04-21T14:53:25.294Z"},"accession":"S-EPMC10545837","cross_references":{"pubmed":["37221235"],"doi":["10.1038/s41401-023-01105-7"]}}